|
1
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dyzmann-Sroka A and Malicki J: Cancer
incidence and mortality in the greater Poland region-analysis of
the year 2010 and future trends. Rep Pract Oncol Radiother.
19:296–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Swiderska M, Choromańska B, Dąbrowska E,
Konarzewska-Duchnowska E, Choromańska K, Szczurko G, Myśliwiec P,
Dadan J, Ladny JR and Zwierz K: The diagnostics of colorectal
cancer. Contemp Oncol (Pozn). 18:1–6. 2014.
|
|
4
|
Dalmay T: MicroRNAs and cancer. J Intern
Med. 263:366–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Negrini M, Ferracin M, Sabbioni S and
Croce CM: MicroRNAs in human cancer: From research to therapy. J
Cell Sci. 120:1833–1840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tokarz P and Blasiak J: The role of
microRNA in metastatic colorectal cancer and its significance in
cancer prognosis and treatment. Acta Biochim Pol. 59:467–74.
2012.PubMed/NCBI
|
|
10
|
Liu C and Tang DG: MicroRNA regulation of
cancer stem cells. Cancer Res. 71:5950–5954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lai X, Wolkenhauer O and Vera J: Modeling
miRNA regulation in cancer signaling systems: miR-34a regulation of
the p53/Sirt1 signaling module. Methods Mol Biol. 880:87–108. 2012.
View Article : Google Scholar
|
|
12
|
Chen F and Hu SJ: Effect of microRNA-34a
in cell cycle, differentiation and apoptosis: A review. J Biochem
Mol Toxicol. 26:79–86. 2012. View Article : Google Scholar
|
|
13
|
Hermeking H: The miR-34 family in cancer
and apoptosis. Cell Death Differ. 17:193–199. 2010. View Article : Google Scholar
|
|
14
|
Ma Y, Bao-Han W, Lv X, Su Y, Zhao X, Yin
Y, Zhang X, Zhou Z, MacNaughton WK and Wang H: MicroRNA-34a
mediates the autocrine signaling of PAR2-activating proteinase and
its role in colonic cancer cell proliferation. PLoS One.
8:e723832013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bu P, Chen KY, Chen JH, Wang L, Walters J,
Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A
microRNA miR-34a-regulated bimodal switch targets Notch in colon
cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Winton DJ: miR-34a sets the 'sweet spot'
for notch in colorectal cancer stem cells. Cell Stem Cell.
12:499–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamakuchi M, Ferlito M and Lowenstein CJ:
miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci
USA. 105:13421–13426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tazawa H, Tsuchiya N, Izumiya M and
Nakagama H: Tumor-suppressive miR-34a induces senescence-like
growth arrest through modulation of the E2F pathway in human colon
cancer cells. Proc Natl Acad Sci USA. 104:15472–15477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rudy DR and Zdon MJ: Update on colorectal
cancer. Am Fam Physician. 61:1759–1770. 1773–1774. 2000.PubMed/NCBI
|
|
20
|
Jass JR and Morson BC: Reporting
colorectal cancer. J Clin Pathol. 40:1016–1023. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu Y, Wang Y, Guan B, Rao Q, Wang J, Ma
H, Zhang Z and Zhou X: C-kit and PDGFRA gene mutations in triple
negative breast cancer. Int J Clin Exp Pathol. 7:4280–4285.
2014.PubMed/NCBI
|
|
22
|
Stock AM, Hahn SA, Troost G, Niggemann B,
Zänker KS and Entschladen F: Induction of pancreatic cancer cell
migration by an autocrine epidermal growth factor receptor
activation. Exp Cell Res. 326:307–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Demoulin JB and Essaghir A: PDGF receptor
signaling networks in normal and cancer cells. Cytokine Growth
Factor Rev. 25:273–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hayes BJ, Riehle KJ, Shimizu-Albergine M,
Bauer RL, Hudkins KL, Johansson F, Yeh MM, Mahoney WM Jr, Yeung RS,
Campbell JS, et al: Activation of platelet-derived growth factor
receptor alpha contributes to liver fibrosis. PLoS One.
9:e929252014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roh JW, Huang J, Hu W, Yang X, Jennings
NB, Sehgal V, Sohn BH, Han HD, Lee SJ, Thanapprapasr D, et al:
Biologic effects of platelet-derived growth factor receptor α
blockade in uterine cancer. Clin Cancer Res. 20:2740–2750. 2014.
View Article : Google Scholar : PubMed/NCBI
|
